Evidence map›Paper›PMID 40240051›Full record

ReviewZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery2025

[Research progress on strontium modified β-tricalcium phosphate composite biomaterials with immune regulatory properties].

Huanxi Li, Xingyu Shan, Hongda Wang, Zhimin Tian, Chunnuo He, Haoqiang Zhang

Abstract readReviewEnglish Abstract
In one paragraph

Review in Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huanxi LiDepartment of Joint Surgery, the 940th Hospital of Chinese PLA Joint Logistics Support Force, Lanzhou Gansu, 730000, P. R. China.
Xingyu ShanThe First Clinical College of Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou Gansu, 730000, P. R. China.
Hongda WangThe First Clinical College of Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou Gansu, 730000, P. R. China.
Zhimin TianThe First Clinical College of Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou Gansu, 730000, P. R. China.
Chunnuo HeThe First Clinical College of Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou Gansu, 730000, P. R. China.
Haoqiang ZhangDepartment of Joint Surgery, the 940th Hospital of Chinese PLA Joint Logistics Support Force, Lanzhou Gansu, 730000, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To review the research progress of strontium (Sr) modified β-tricalcium phosphate composite biomaterials (SrTCP) promoting osteogenesis through immune regulation, and provides reference and theoretical support for the further development and research of SrTCP bone repair materials in bone tissue engineering in the future. Methods: The literature about SrTCP promoting osteogenesis through immune regulation at home and abroad in recent years was extensively reviewed, and the preparation methods, immune mechanism and application of promoting osteogenesis were summarized and analyzed. Results: The preparation methods of SrTCP include solid-state reaction sintering method, solution combustion quenching method, direct doping method, ion substitution method, Conclusion: At present, studies have shown that SrTCP can promote bone defect repair through immune regulation. Subsequent studies can start from the control of the optimal repair concentration and release rate of Sr, and further clarify the specific mechanism of SrTCP in promoting angiogenesis and anti oxidative stress, which is helpful to develop new materials for bone defect repair.

Indexed as

Biocompatible MaterialsBone SubstitutesCalcium PhosphatesOsteogenesisStrontiumAnimalsBone RegenerationHumansMacrophagesNeovascularization, PhysiologicTissue EngineeringTissue Scaffoldsbeta-tricalcium phosphateBiocompatible MaterialsBone SubstitutesCalcium PhosphatesStrontiumBone repairimmune regulationstrontiumβ-tricalcium phosphate

Identifiers

PMID40240051
PMCPMC12011495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.